Rechargeable Pacemaker Technology in Deep Brain Stimulation: A Step Forward, But Not for Everyone

BACKGROUND: Rechargeable implantable pulse generator (IPG) technology has several advantages over non‐rechargeable systems and is routinely used now in deep brain stimulation (DBS). Little is known about the occasional need and the circumstances for switching back to non‐rechargeable technology. CAS...

Descripción completa

Detalles Bibliográficos
Autores principales: Runge, Joachim, Nagel, Johanna M., Schrader, Christoph, Saryyeva, Assel, Krauss, Joachim K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8485590/
https://www.ncbi.nlm.nih.gov/pubmed/34631947
http://dx.doi.org/10.1002/mdc3.13306
Descripción
Sumario:BACKGROUND: Rechargeable implantable pulse generator (IPG) technology has several advantages over non‐rechargeable systems and is routinely used now in deep brain stimulation (DBS). Little is known about the occasional need and the circumstances for switching back to non‐rechargeable technology. CASES: Out of a cohort of 640 patients, 102 patients received a rechargeable IPG at first implantation or at the time of replacement surgery. Out of these, 3 patients underwent preemptive replacement with non‐rechargeable devices for the following reasons: dissatisfaction with handling and recharge frequency (pallidal DBS in advanced Parkinson's disease/dystonia), severe DBS OFF status subsequent to missed recharging (subthalamic DBS in Parkinson's disease) and twiddler's syndrome (nucleus accumbens DBS in alcohol dependency). CONCLUSIONS: Although rechargeable IPG technology has been received well and is used widely, there are unexpected scenarios that require replacement surgery with non‐rechargeable IPGs.

Ejemplares similares